nodes	percent_of_prediction	percent_of_DWPC	metapath
Pilocarpine—CYP2A6—Fluorouracil—urinary bladder cancer	0.135	0.409	CbGbCtD
Pilocarpine—CYP3A4—Thiotepa—urinary bladder cancer	0.0829	0.252	CbGbCtD
Pilocarpine—CYP2E1—Etoposide—urinary bladder cancer	0.0742	0.225	CbGbCtD
Pilocarpine—CHRM3—ureter—urinary bladder cancer	0.0445	0.273	CbGeAlD
Pilocarpine—CHRM3—muscle of abdomen—urinary bladder cancer	0.032	0.197	CbGeAlD
Pilocarpine—CYP3A4—Etoposide—urinary bladder cancer	0.0225	0.0682	CbGbCtD
Pilocarpine—CYP3A4—Doxorubicin—urinary bladder cancer	0.0153	0.0465	CbGbCtD
Pilocarpine—CYP2E1—urine—urinary bladder cancer	0.00987	0.0607	CbGeAlD
Pilocarpine—CYP3A4—urine—urinary bladder cancer	0.00794	0.0488	CbGeAlD
Pilocarpine—CYP2A6—prostate gland—urinary bladder cancer	0.0075	0.0461	CbGeAlD
Pilocarpine—CHRM2—prostate gland—urinary bladder cancer	0.00637	0.0392	CbGeAlD
Pilocarpine—CYP2A6—seminal vesicle—urinary bladder cancer	0.00634	0.039	CbGeAlD
Pilocarpine—CHRM1—prostate gland—urinary bladder cancer	0.0058	0.0356	CbGeAlD
Pilocarpine—CHRM3—prostate gland—urinary bladder cancer	0.00519	0.0319	CbGeAlD
Pilocarpine—CYP2A6—vagina—urinary bladder cancer	0.0037	0.0228	CbGeAlD
Pilocarpine—CHRM3—smooth muscle tissue—urinary bladder cancer	0.00367	0.0226	CbGeAlD
Pilocarpine—CYP2E1—prostate gland—urinary bladder cancer	0.00354	0.0218	CbGeAlD
Pilocarpine—CHRM3—renal system—urinary bladder cancer	0.00354	0.0217	CbGeAlD
Pilocarpine—CHRM3—urethra—urinary bladder cancer	0.00347	0.0214	CbGeAlD
Pilocarpine—CHRM1—female reproductive system—urinary bladder cancer	0.00316	0.0195	CbGeAlD
Pilocarpine—CYP2E1—seminal vesicle—urinary bladder cancer	0.003	0.0184	CbGeAlD
Pilocarpine—CHRM3—female reproductive system—urinary bladder cancer	0.00283	0.0174	CbGeAlD
Pilocarpine—CYP2E1—renal system—urinary bladder cancer	0.00242	0.0148	CbGeAlD
Pilocarpine—CYP2E1—urethra—urinary bladder cancer	0.00237	0.0146	CbGeAlD
Pilocarpine—CYP3A4—renal system—urinary bladder cancer	0.00194	0.0119	CbGeAlD
Pilocarpine—CYP2E1—female reproductive system—urinary bladder cancer	0.00193	0.0119	CbGeAlD
Pilocarpine—CYP3A4—female reproductive system—urinary bladder cancer	0.00156	0.00957	CbGeAlD
Pilocarpine—Paraesthesia—Etoposide—urinary bladder cancer	0.000365	0.000793	CcSEcCtD
Pilocarpine—Haematuria—Methotrexate—urinary bladder cancer	0.000364	0.000791	CcSEcCtD
Pilocarpine—Pancreatitis—Doxorubicin—urinary bladder cancer	0.000363	0.00079	CcSEcCtD
Pilocarpine—Dyspnoea—Etoposide—urinary bladder cancer	0.000362	0.000787	CcSEcCtD
Pilocarpine—Somnolence—Etoposide—urinary bladder cancer	0.000361	0.000785	CcSEcCtD
Pilocarpine—Angina pectoris—Doxorubicin—urinary bladder cancer	0.000361	0.000785	CcSEcCtD
Pilocarpine—Epistaxis—Methotrexate—urinary bladder cancer	0.00036	0.000782	CcSEcCtD
Pilocarpine—Vomiting—Thiotepa—urinary bladder cancer	0.00036	0.000782	CcSEcCtD
Pilocarpine—Pneumonia—Epirubicin—urinary bladder cancer	0.000359	0.000781	CcSEcCtD
Pilocarpine—Rash—Thiotepa—urinary bladder cancer	0.000357	0.000775	CcSEcCtD
Pilocarpine—Bronchitis—Doxorubicin—urinary bladder cancer	0.000356	0.000775	CcSEcCtD
Pilocarpine—Dermatitis—Thiotepa—urinary bladder cancer	0.000356	0.000774	CcSEcCtD
Pilocarpine—Headache—Thiotepa—urinary bladder cancer	0.000354	0.00077	CcSEcCtD
Pilocarpine—Decreased appetite—Etoposide—urinary bladder cancer	0.000353	0.000768	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000351	0.000762	CcSEcCtD
Pilocarpine—Body temperature increased—Cisplatin—urinary bladder cancer	0.000351	0.000762	CcSEcCtD
Pilocarpine—Stomatitis—Epirubicin—urinary bladder cancer	0.000348	0.000757	CcSEcCtD
Pilocarpine—Pain—Etoposide—urinary bladder cancer	0.000347	0.000755	CcSEcCtD
Pilocarpine—Constipation—Etoposide—urinary bladder cancer	0.000347	0.000755	CcSEcCtD
Pilocarpine—Conjunctivitis—Epirubicin—urinary bladder cancer	0.000347	0.000754	CcSEcCtD
Pilocarpine—Urinary tract infection—Epirubicin—urinary bladder cancer	0.000347	0.000754	CcSEcCtD
Pilocarpine—Dysuria—Doxorubicin—urinary bladder cancer	0.000347	0.000753	CcSEcCtD
Pilocarpine—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000345	0.000749	CcSEcCtD
Pilocarpine—Hepatitis—Methotrexate—urinary bladder cancer	0.000343	0.000745	CcSEcCtD
Pilocarpine—Sweating—Epirubicin—urinary bladder cancer	0.000342	0.000744	CcSEcCtD
Pilocarpine—Pollakiuria—Doxorubicin—urinary bladder cancer	0.000342	0.000744	CcSEcCtD
Pilocarpine—Asthenia—Gemcitabine—urinary bladder cancer	0.000341	0.000742	CcSEcCtD
Pilocarpine—Haematuria—Epirubicin—urinary bladder cancer	0.000341	0.00074	CcSEcCtD
Pilocarpine—Pharyngitis—Methotrexate—urinary bladder cancer	0.00034	0.000739	CcSEcCtD
Pilocarpine—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.000338	0.000735	CcSEcCtD
Pilocarpine—Epistaxis—Epirubicin—urinary bladder cancer	0.000337	0.000732	CcSEcCtD
Pilocarpine—Pruritus—Gemcitabine—urinary bladder cancer	0.000337	0.000732	CcSEcCtD
Pilocarpine—Nausea—Thiotepa—urinary bladder cancer	0.000336	0.00073	CcSEcCtD
Pilocarpine—Sinusitis—Epirubicin—urinary bladder cancer	0.000335	0.000728	CcSEcCtD
Pilocarpine—Feeling abnormal—Etoposide—urinary bladder cancer	0.000335	0.000728	CcSEcCtD
Pilocarpine—Pneumonia—Doxorubicin—urinary bladder cancer	0.000332	0.000722	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000332	0.000722	CcSEcCtD
Pilocarpine—Pruritus—Fluorouracil—urinary bladder cancer	0.000331	0.000719	CcSEcCtD
Pilocarpine—Visual impairment—Methotrexate—urinary bladder cancer	0.00033	0.000717	CcSEcCtD
Pilocarpine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000327	0.00071	CcSEcCtD
Pilocarpine—Bradycardia—Epirubicin—urinary bladder cancer	0.000326	0.000709	CcSEcCtD
Pilocarpine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000326	0.000708	CcSEcCtD
Pilocarpine—Stomatitis—Doxorubicin—urinary bladder cancer	0.000322	0.0007	CcSEcCtD
Pilocarpine—Rhinitis—Epirubicin—urinary bladder cancer	0.000321	0.000699	CcSEcCtD
Pilocarpine—Abdominal pain—Etoposide—urinary bladder cancer	0.000321	0.000698	CcSEcCtD
Pilocarpine—Body temperature increased—Etoposide—urinary bladder cancer	0.000321	0.000698	CcSEcCtD
Pilocarpine—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000321	0.000698	CcSEcCtD
Pilocarpine—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000321	0.000698	CcSEcCtD
Pilocarpine—Hepatitis—Epirubicin—urinary bladder cancer	0.000321	0.000697	CcSEcCtD
Pilocarpine—Eye disorder—Methotrexate—urinary bladder cancer	0.00032	0.000696	CcSEcCtD
Pilocarpine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00032	0.000696	CcSEcCtD
Pilocarpine—Tinnitus—Methotrexate—urinary bladder cancer	0.000319	0.000694	CcSEcCtD
Pilocarpine—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000319	0.000693	CcSEcCtD
Pilocarpine—Asthenia—Cisplatin—urinary bladder cancer	0.000318	0.000692	CcSEcCtD
Pilocarpine—Pharyngitis—Epirubicin—urinary bladder cancer	0.000318	0.000692	CcSEcCtD
Pilocarpine—Sweating—Doxorubicin—urinary bladder cancer	0.000317	0.000688	CcSEcCtD
Pilocarpine—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000316	0.000686	CcSEcCtD
Pilocarpine—Haematuria—Doxorubicin—urinary bladder cancer	0.000315	0.000685	CcSEcCtD
Pilocarpine—Epistaxis—Doxorubicin—urinary bladder cancer	0.000312	0.000677	CcSEcCtD
Pilocarpine—Sinusitis—Doxorubicin—urinary bladder cancer	0.00031	0.000674	CcSEcCtD
Pilocarpine—Dizziness—Fluorouracil—urinary bladder cancer	0.000309	0.000672	CcSEcCtD
Pilocarpine—Visual impairment—Epirubicin—urinary bladder cancer	0.000309	0.000671	CcSEcCtD
Pilocarpine—Chills—Methotrexate—urinary bladder cancer	0.000307	0.000668	CcSEcCtD
Pilocarpine—Diarrhoea—Cisplatin—urinary bladder cancer	0.000303	0.00066	CcSEcCtD
Pilocarpine—Alopecia—Methotrexate—urinary bladder cancer	0.000303	0.000658	CcSEcCtD
Pilocarpine—Vomiting—Gemcitabine—urinary bladder cancer	0.000303	0.000658	CcSEcCtD
Pilocarpine—Bradycardia—Doxorubicin—urinary bladder cancer	0.000302	0.000656	CcSEcCtD
Pilocarpine—Rash—Gemcitabine—urinary bladder cancer	0.0003	0.000652	CcSEcCtD
Pilocarpine—Dermatitis—Gemcitabine—urinary bladder cancer	0.0003	0.000651	CcSEcCtD
Pilocarpine—Eye disorder—Epirubicin—urinary bladder cancer	0.0003	0.000651	CcSEcCtD
Pilocarpine—Hypersensitivity—Etoposide—urinary bladder cancer	0.000299	0.000651	CcSEcCtD
Pilocarpine—Tinnitus—Epirubicin—urinary bladder cancer	0.000299	0.00065	CcSEcCtD
Pilocarpine—Headache—Gemcitabine—urinary bladder cancer	0.000298	0.000648	CcSEcCtD
Pilocarpine—Flushing—Epirubicin—urinary bladder cancer	0.000298	0.000647	CcSEcCtD
Pilocarpine—Vomiting—Fluorouracil—urinary bladder cancer	0.000297	0.000646	CcSEcCtD
Pilocarpine—Rhinitis—Doxorubicin—urinary bladder cancer	0.000297	0.000646	CcSEcCtD
Pilocarpine—Hepatitis—Doxorubicin—urinary bladder cancer	0.000297	0.000645	CcSEcCtD
Pilocarpine—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000295	0.000641	CcSEcCtD
Pilocarpine—Rash—Fluorouracil—urinary bladder cancer	0.000295	0.000641	CcSEcCtD
Pilocarpine—Dermatitis—Fluorouracil—urinary bladder cancer	0.000295	0.000641	CcSEcCtD
Pilocarpine—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000294	0.00064	CcSEcCtD
Pilocarpine—Headache—Fluorouracil—urinary bladder cancer	0.000293	0.000637	CcSEcCtD
Pilocarpine—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000292	0.000635	CcSEcCtD
Pilocarpine—Dysgeusia—Methotrexate—urinary bladder cancer	0.000292	0.000635	CcSEcCtD
Pilocarpine—Asthenia—Etoposide—urinary bladder cancer	0.000292	0.000634	CcSEcCtD
Pilocarpine—Back pain—Methotrexate—urinary bladder cancer	0.000288	0.000627	CcSEcCtD
Pilocarpine—Chills—Epirubicin—urinary bladder cancer	0.000288	0.000625	CcSEcCtD
Pilocarpine—Pruritus—Etoposide—urinary bladder cancer	0.000287	0.000625	CcSEcCtD
Pilocarpine—Arrhythmia—Epirubicin—urinary bladder cancer	0.000286	0.000622	CcSEcCtD
Pilocarpine—Visual impairment—Doxorubicin—urinary bladder cancer	0.000286	0.000621	CcSEcCtD
Pilocarpine—Alopecia—Epirubicin—urinary bladder cancer	0.000283	0.000616	CcSEcCtD
Pilocarpine—Nausea—Gemcitabine—urinary bladder cancer	0.000283	0.000614	CcSEcCtD
Pilocarpine—Vomiting—Cisplatin—urinary bladder cancer	0.000282	0.000613	CcSEcCtD
Pilocarpine—Vision blurred—Methotrexate—urinary bladder cancer	0.000281	0.000611	CcSEcCtD
Pilocarpine—Rash—Cisplatin—urinary bladder cancer	0.00028	0.000608	CcSEcCtD
Pilocarpine—Dermatitis—Cisplatin—urinary bladder cancer	0.000279	0.000607	CcSEcCtD
Pilocarpine—Diarrhoea—Etoposide—urinary bladder cancer	0.000278	0.000604	CcSEcCtD
Pilocarpine—Nausea—Fluorouracil—urinary bladder cancer	0.000278	0.000604	CcSEcCtD
Pilocarpine—Eye disorder—Doxorubicin—urinary bladder cancer	0.000277	0.000602	CcSEcCtD
Pilocarpine—Tinnitus—Doxorubicin—urinary bladder cancer	0.000277	0.000601	CcSEcCtD
Pilocarpine—Flushing—Doxorubicin—urinary bladder cancer	0.000275	0.000598	CcSEcCtD
Pilocarpine—Flatulence—Epirubicin—urinary bladder cancer	0.000275	0.000598	CcSEcCtD
Pilocarpine—Tension—Epirubicin—urinary bladder cancer	0.000274	0.000595	CcSEcCtD
Pilocarpine—Dysgeusia—Epirubicin—urinary bladder cancer	0.000273	0.000594	CcSEcCtD
Pilocarpine—Nervousness—Epirubicin—urinary bladder cancer	0.000271	0.000589	CcSEcCtD
Pilocarpine—Back pain—Epirubicin—urinary bladder cancer	0.00027	0.000587	CcSEcCtD
Pilocarpine—Dizziness—Etoposide—urinary bladder cancer	0.000269	0.000584	CcSEcCtD
Pilocarpine—Muscle spasms—Epirubicin—urinary bladder cancer	0.000268	0.000583	CcSEcCtD
Pilocarpine—Leukopenia—Methotrexate—urinary bladder cancer	0.000267	0.00058	CcSEcCtD
Pilocarpine—Chills—Doxorubicin—urinary bladder cancer	0.000266	0.000578	CcSEcCtD
Pilocarpine—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000265	0.000576	CcSEcCtD
Pilocarpine—Nausea—Cisplatin—urinary bladder cancer	0.000263	0.000573	CcSEcCtD
Pilocarpine—Vision blurred—Epirubicin—urinary bladder cancer	0.000263	0.000572	CcSEcCtD
Pilocarpine—Alopecia—Doxorubicin—urinary bladder cancer	0.000262	0.00057	CcSEcCtD
Pilocarpine—Cough—Methotrexate—urinary bladder cancer	0.00026	0.000566	CcSEcCtD
Pilocarpine—Vomiting—Etoposide—urinary bladder cancer	0.000258	0.000561	CcSEcCtD
Pilocarpine—Agitation—Epirubicin—urinary bladder cancer	0.000256	0.000557	CcSEcCtD
Pilocarpine—Rash—Etoposide—urinary bladder cancer	0.000256	0.000557	CcSEcCtD
Pilocarpine—Dermatitis—Etoposide—urinary bladder cancer	0.000256	0.000556	CcSEcCtD
Pilocarpine—Headache—Etoposide—urinary bladder cancer	0.000255	0.000553	CcSEcCtD
Pilocarpine—Flatulence—Doxorubicin—urinary bladder cancer	0.000254	0.000553	CcSEcCtD
Pilocarpine—Arthralgia—Methotrexate—urinary bladder cancer	0.000254	0.000552	CcSEcCtD
Pilocarpine—Myalgia—Methotrexate—urinary bladder cancer	0.000254	0.000552	CcSEcCtD
Pilocarpine—Chest pain—Methotrexate—urinary bladder cancer	0.000254	0.000552	CcSEcCtD
Pilocarpine—Tension—Doxorubicin—urinary bladder cancer	0.000253	0.000551	CcSEcCtD
Pilocarpine—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000253	0.00055	CcSEcCtD
Pilocarpine—Discomfort—Methotrexate—urinary bladder cancer	0.000251	0.000545	CcSEcCtD
Pilocarpine—Nervousness—Doxorubicin—urinary bladder cancer	0.000251	0.000545	CcSEcCtD
Pilocarpine—Syncope—Epirubicin—urinary bladder cancer	0.00025	0.000544	CcSEcCtD
Pilocarpine—Leukopenia—Epirubicin—urinary bladder cancer	0.00025	0.000543	CcSEcCtD
Pilocarpine—Back pain—Doxorubicin—urinary bladder cancer	0.00025	0.000543	CcSEcCtD
Pilocarpine—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000248	0.00054	CcSEcCtD
Pilocarpine—Palpitations—Epirubicin—urinary bladder cancer	0.000247	0.000536	CcSEcCtD
Pilocarpine—Confusional state—Methotrexate—urinary bladder cancer	0.000245	0.000533	CcSEcCtD
Pilocarpine—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000245	0.000533	CcSEcCtD
Pilocarpine—Cough—Epirubicin—urinary bladder cancer	0.000244	0.000529	CcSEcCtD
Pilocarpine—Vision blurred—Doxorubicin—urinary bladder cancer	0.000243	0.000529	CcSEcCtD
Pilocarpine—Infection—Methotrexate—urinary bladder cancer	0.000242	0.000525	CcSEcCtD
Pilocarpine—Nausea—Etoposide—urinary bladder cancer	0.000241	0.000525	CcSEcCtD
Pilocarpine—Hypertension—Epirubicin—urinary bladder cancer	0.000241	0.000524	CcSEcCtD
Pilocarpine—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000238	0.000518	CcSEcCtD
Pilocarpine—Myalgia—Epirubicin—urinary bladder cancer	0.000238	0.000516	CcSEcCtD
Pilocarpine—Chest pain—Epirubicin—urinary bladder cancer	0.000238	0.000516	CcSEcCtD
Pilocarpine—Arthralgia—Epirubicin—urinary bladder cancer	0.000238	0.000516	CcSEcCtD
Pilocarpine—Agitation—Doxorubicin—urinary bladder cancer	0.000237	0.000516	CcSEcCtD
Pilocarpine—Anxiety—Epirubicin—urinary bladder cancer	0.000237	0.000515	CcSEcCtD
Pilocarpine—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000235	0.000511	CcSEcCtD
Pilocarpine—Discomfort—Epirubicin—urinary bladder cancer	0.000235	0.00051	CcSEcCtD
Pilocarpine—Anorexia—Methotrexate—urinary bladder cancer	0.000232	0.000504	CcSEcCtD
Pilocarpine—Syncope—Doxorubicin—urinary bladder cancer	0.000232	0.000503	CcSEcCtD
Pilocarpine—Leukopenia—Doxorubicin—urinary bladder cancer	0.000231	0.000502	CcSEcCtD
Pilocarpine—Confusional state—Epirubicin—urinary bladder cancer	0.00023	0.000499	CcSEcCtD
Pilocarpine—Palpitations—Doxorubicin—urinary bladder cancer	0.000228	0.000496	CcSEcCtD
Pilocarpine—Oedema—Epirubicin—urinary bladder cancer	0.000228	0.000495	CcSEcCtD
Pilocarpine—Hypotension—Methotrexate—urinary bladder cancer	0.000227	0.000494	CcSEcCtD
Pilocarpine—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000227	0.000493	CcSEcCtD
Pilocarpine—Infection—Epirubicin—urinary bladder cancer	0.000226	0.000492	CcSEcCtD
Pilocarpine—Cough—Doxorubicin—urinary bladder cancer	0.000225	0.00049	CcSEcCtD
Pilocarpine—Shock—Epirubicin—urinary bladder cancer	0.000224	0.000487	CcSEcCtD
Pilocarpine—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000223	0.000485	CcSEcCtD
Pilocarpine—Hypertension—Doxorubicin—urinary bladder cancer	0.000223	0.000485	CcSEcCtD
Pilocarpine—Tachycardia—Epirubicin—urinary bladder cancer	0.000222	0.000483	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000222	0.000482	CcSEcCtD
Pilocarpine—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.00022	0.000479	CcSEcCtD
Pilocarpine—Insomnia—Methotrexate—urinary bladder cancer	0.00022	0.000478	CcSEcCtD
Pilocarpine—Myalgia—Doxorubicin—urinary bladder cancer	0.00022	0.000478	CcSEcCtD
Pilocarpine—Chest pain—Doxorubicin—urinary bladder cancer	0.00022	0.000478	CcSEcCtD
Pilocarpine—Arthralgia—Doxorubicin—urinary bladder cancer	0.00022	0.000478	CcSEcCtD
Pilocarpine—Anxiety—Doxorubicin—urinary bladder cancer	0.000219	0.000476	CcSEcCtD
Pilocarpine—Paraesthesia—Methotrexate—urinary bladder cancer	0.000219	0.000475	CcSEcCtD
Pilocarpine—Discomfort—Doxorubicin—urinary bladder cancer	0.000217	0.000472	CcSEcCtD
Pilocarpine—Anorexia—Epirubicin—urinary bladder cancer	0.000217	0.000472	CcSEcCtD
Pilocarpine—Dyspnoea—Methotrexate—urinary bladder cancer	0.000217	0.000472	CcSEcCtD
Pilocarpine—Somnolence—Methotrexate—urinary bladder cancer	0.000216	0.00047	CcSEcCtD
Pilocarpine—Dyspepsia—Methotrexate—urinary bladder cancer	0.000214	0.000466	CcSEcCtD
Pilocarpine—Hypotension—Epirubicin—urinary bladder cancer	0.000213	0.000463	CcSEcCtD
Pilocarpine—Confusional state—Doxorubicin—urinary bladder cancer	0.000213	0.000462	CcSEcCtD
Pilocarpine—Decreased appetite—Methotrexate—urinary bladder cancer	0.000212	0.00046	CcSEcCtD
Pilocarpine—Oedema—Doxorubicin—urinary bladder cancer	0.000211	0.000458	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.00021	0.000457	CcSEcCtD
Pilocarpine—Infection—Doxorubicin—urinary bladder cancer	0.000209	0.000455	CcSEcCtD
Pilocarpine—Pain—Methotrexate—urinary bladder cancer	0.000208	0.000452	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000208	0.000451	CcSEcCtD
Pilocarpine—Shock—Doxorubicin—urinary bladder cancer	0.000207	0.000451	CcSEcCtD
Pilocarpine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000206	0.000448	CcSEcCtD
Pilocarpine—Insomnia—Epirubicin—urinary bladder cancer	0.000206	0.000448	CcSEcCtD
Pilocarpine—Tachycardia—Doxorubicin—urinary bladder cancer	0.000206	0.000447	CcSEcCtD
Pilocarpine—Paraesthesia—Epirubicin—urinary bladder cancer	0.000205	0.000444	CcSEcCtD
Pilocarpine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000204	0.000443	CcSEcCtD
Pilocarpine—Dyspnoea—Epirubicin—urinary bladder cancer	0.000203	0.000441	CcSEcCtD
Pilocarpine—Somnolence—Epirubicin—urinary bladder cancer	0.000202	0.00044	CcSEcCtD
Pilocarpine—Anorexia—Doxorubicin—urinary bladder cancer	0.000201	0.000437	CcSEcCtD
Pilocarpine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000201	0.000436	CcSEcCtD
Pilocarpine—Dyspepsia—Epirubicin—urinary bladder cancer	0.0002	0.000436	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000199	0.000433	CcSEcCtD
Pilocarpine—Decreased appetite—Epirubicin—urinary bladder cancer	0.000198	0.00043	CcSEcCtD
Pilocarpine—Hypotension—Doxorubicin—urinary bladder cancer	0.000197	0.000428	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000197	0.000427	CcSEcCtD
Pilocarpine—Pain—Epirubicin—urinary bladder cancer	0.000195	0.000423	CcSEcCtD
Pilocarpine—Constipation—Epirubicin—urinary bladder cancer	0.000195	0.000423	CcSEcCtD
Pilocarpine—Abdominal pain—Methotrexate—urinary bladder cancer	0.000192	0.000418	CcSEcCtD
Pilocarpine—Body temperature increased—Methotrexate—urinary bladder cancer	0.000192	0.000418	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000192	0.000417	CcSEcCtD
Pilocarpine—Insomnia—Doxorubicin—urinary bladder cancer	0.000191	0.000414	CcSEcCtD
Pilocarpine—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000189	0.000411	CcSEcCtD
Pilocarpine—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000188	0.000408	CcSEcCtD
Pilocarpine—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000188	0.000408	CcSEcCtD
Pilocarpine—Somnolence—Doxorubicin—urinary bladder cancer	0.000187	0.000407	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000186	0.000405	CcSEcCtD
Pilocarpine—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000186	0.000403	CcSEcCtD
Pilocarpine—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000183	0.000398	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000182	0.000395	CcSEcCtD
Pilocarpine—Pain—Doxorubicin—urinary bladder cancer	0.00018	0.000392	CcSEcCtD
Pilocarpine—Constipation—Doxorubicin—urinary bladder cancer	0.00018	0.000392	CcSEcCtD
Pilocarpine—Body temperature increased—Epirubicin—urinary bladder cancer	0.00018	0.000391	CcSEcCtD
Pilocarpine—Abdominal pain—Epirubicin—urinary bladder cancer	0.00018	0.000391	CcSEcCtD
Pilocarpine—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000179	0.00039	CcSEcCtD
Pilocarpine—Asthenia—Methotrexate—urinary bladder cancer	0.000175	0.00038	CcSEcCtD
Pilocarpine—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000174	0.000377	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000172	0.000375	CcSEcCtD
Pilocarpine—Pruritus—Methotrexate—urinary bladder cancer	0.000172	0.000374	CcSEcCtD
Pilocarpine—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000168	0.000365	CcSEcCtD
Pilocarpine—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000167	0.000362	CcSEcCtD
Pilocarpine—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000167	0.000362	CcSEcCtD
Pilocarpine—Diarrhoea—Methotrexate—urinary bladder cancer	0.000167	0.000362	CcSEcCtD
Pilocarpine—Asthenia—Epirubicin—urinary bladder cancer	0.000163	0.000355	CcSEcCtD
Pilocarpine—Pruritus—Epirubicin—urinary bladder cancer	0.000161	0.00035	CcSEcCtD
Pilocarpine—Dizziness—Methotrexate—urinary bladder cancer	0.000161	0.00035	CcSEcCtD
Pilocarpine—Diarrhoea—Epirubicin—urinary bladder cancer	0.000156	0.000339	CcSEcCtD
Pilocarpine—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000155	0.000337	CcSEcCtD
Pilocarpine—Vomiting—Methotrexate—urinary bladder cancer	0.000155	0.000336	CcSEcCtD
Pilocarpine—Rash—Methotrexate—urinary bladder cancer	0.000153	0.000334	CcSEcCtD
Pilocarpine—Dermatitis—Methotrexate—urinary bladder cancer	0.000153	0.000333	CcSEcCtD
Pilocarpine—Headache—Methotrexate—urinary bladder cancer	0.000152	0.000331	CcSEcCtD
Pilocarpine—Asthenia—Doxorubicin—urinary bladder cancer	0.000151	0.000329	CcSEcCtD
Pilocarpine—Dizziness—Epirubicin—urinary bladder cancer	0.000151	0.000327	CcSEcCtD
Pilocarpine—Pruritus—Doxorubicin—urinary bladder cancer	0.000149	0.000324	CcSEcCtD
Pilocarpine—Vomiting—Epirubicin—urinary bladder cancer	0.000145	0.000315	CcSEcCtD
Pilocarpine—Nausea—Methotrexate—urinary bladder cancer	0.000145	0.000314	CcSEcCtD
Pilocarpine—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000144	0.000313	CcSEcCtD
Pilocarpine—Rash—Epirubicin—urinary bladder cancer	0.000144	0.000312	CcSEcCtD
Pilocarpine—Dermatitis—Epirubicin—urinary bladder cancer	0.000143	0.000312	CcSEcCtD
Pilocarpine—Headache—Epirubicin—urinary bladder cancer	0.000143	0.00031	CcSEcCtD
Pilocarpine—Dizziness—Doxorubicin—urinary bladder cancer	0.000139	0.000303	CcSEcCtD
Pilocarpine—Nausea—Epirubicin—urinary bladder cancer	0.000135	0.000294	CcSEcCtD
Pilocarpine—Vomiting—Doxorubicin—urinary bladder cancer	0.000134	0.000291	CcSEcCtD
Pilocarpine—Rash—Doxorubicin—urinary bladder cancer	0.000133	0.000289	CcSEcCtD
Pilocarpine—Dermatitis—Doxorubicin—urinary bladder cancer	0.000133	0.000289	CcSEcCtD
Pilocarpine—Headache—Doxorubicin—urinary bladder cancer	0.000132	0.000287	CcSEcCtD
Pilocarpine—Nausea—Doxorubicin—urinary bladder cancer	0.000125	0.000272	CcSEcCtD
Pilocarpine—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.0001	0.00211	CbGpPWpGaD
Pilocarpine—CHRM2—SIDS Susceptibility Pathways—CREBBP—urinary bladder cancer	9.47e-05	0.00199	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—GSTZ1—urinary bladder cancer	9.13e-05	0.00192	CbGpPWpGaD
Pilocarpine—CHRM1—Regulation of Actin Cytoskeleton—RHOA—urinary bladder cancer	9e-05	0.00189	CbGpPWpGaD
Pilocarpine—CHRM3—Regulation of Actin Cytoskeleton—RHOA—urinary bladder cancer	8.97e-05	0.00189	CbGpPWpGaD
Pilocarpine—CHRM1—Circadian rythm related genes—CDK4—urinary bladder cancer	8.97e-05	0.00189	CbGpPWpGaD
Pilocarpine—CHRM2—Regulation of Actin Cytoskeleton—RHOA—urinary bladder cancer	8.88e-05	0.00187	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—GSTO2—urinary bladder cancer	8.65e-05	0.00182	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—NAT1—urinary bladder cancer	8.65e-05	0.00182	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—GSTZ1—urinary bladder cancer	8.56e-05	0.0018	CbGpPWpGaD
Pilocarpine—CHRM1—Circadian rythm related genes—PPARG—urinary bladder cancer	8.15e-05	0.00171	CbGpPWpGaD
Pilocarpine—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	8.13e-05	0.00171	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—GSTO2—urinary bladder cancer	8.12e-05	0.00171	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—NAT1—urinary bladder cancer	8.12e-05	0.00171	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—UGT2B7—urinary bladder cancer	7.91e-05	0.00166	CbGpPWpGaD
Pilocarpine—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	7.88e-05	0.00166	CbGpPWpGaD
Pilocarpine—CHRM2—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	7.52e-05	0.00158	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—UGT2B7—urinary bladder cancer	7.42e-05	0.00156	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—GSTZ1—urinary bladder cancer	7.21e-05	0.00152	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—CYP4B1—urinary bladder cancer	7.13e-05	0.0015	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—GSTO2—urinary bladder cancer	6.84e-05	0.00144	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—NAT1—urinary bladder cancer	6.84e-05	0.00144	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—SLC19A1—urinary bladder cancer	6.73e-05	0.00142	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—CYP4B1—urinary bladder cancer	6.68e-05	0.00141	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—PRSS3—urinary bladder cancer	6.56e-05	0.00138	CbGpPWpGaD
Pilocarpine—CHRM2—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	6.45e-05	0.00136	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—SLC19A1—urinary bladder cancer	6.31e-05	0.00133	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—UGT2B7—urinary bladder cancer	6.25e-05	0.00132	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—PRSS3—urinary bladder cancer	6.15e-05	0.00129	CbGpPWpGaD
Pilocarpine—CHRM1—Regulation of Actin Cytoskeleton—EGFR—urinary bladder cancer	5.77e-05	0.00121	CbGpPWpGaD
Pilocarpine—CHRM3—Regulation of Actin Cytoskeleton—EGFR—urinary bladder cancer	5.76e-05	0.00121	CbGpPWpGaD
Pilocarpine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—urinary bladder cancer	5.7e-05	0.0012	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—CYP4B1—urinary bladder cancer	5.63e-05	0.00118	CbGpPWpGaD
Pilocarpine—CHRM1—Circadian rythm related genes—PTEN—urinary bladder cancer	5.59e-05	0.00118	CbGpPWpGaD
Pilocarpine—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	5.46e-05	0.00115	CbGpPWpGaD
Pilocarpine—CHRM1—Regulation of Actin Cytoskeleton—KRAS—urinary bladder cancer	5.46e-05	0.00115	CbGpPWpGaD
Pilocarpine—CHRM3—Regulation of Actin Cytoskeleton—KRAS—urinary bladder cancer	5.44e-05	0.00114	CbGpPWpGaD
Pilocarpine—CHRM2—G alpha (i) signalling events—CXCL8—urinary bladder cancer	5.42e-05	0.00114	CbGpPWpGaD
Pilocarpine—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	5.39e-05	0.00113	CbGpPWpGaD
Pilocarpine—CHRM2—Regulation of Actin Cytoskeleton—KRAS—urinary bladder cancer	5.39e-05	0.00113	CbGpPWpGaD
Pilocarpine—CHRM1—Circadian rythm related genes—EP300—urinary bladder cancer	5.33e-05	0.00112	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—SLC19A1—urinary bladder cancer	5.32e-05	0.00112	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—TYMP—urinary bladder cancer	5.24e-05	0.0011	CbGpPWpGaD
Pilocarpine—CHRM2—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	5.23e-05	0.0011	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PRSS3—urinary bladder cancer	5.18e-05	0.00109	CbGpPWpGaD
Pilocarpine—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	5.02e-05	0.00106	CbGpPWpGaD
Pilocarpine—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	4.95e-05	0.00104	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—HDAC4—urinary bladder cancer	4.92e-05	0.00104	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—TYMP—urinary bladder cancer	4.92e-05	0.00103	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—HDAC4—urinary bladder cancer	4.91e-05	0.00103	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—HDAC4—urinary bladder cancer	4.86e-05	0.00102	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—NAT2—urinary bladder cancer	4.74e-05	0.000997	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—NAT2—urinary bladder cancer	4.45e-05	0.000935	CbGpPWpGaD
Pilocarpine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—urinary bladder cancer	4.36e-05	0.000918	CbGpPWpGaD
Pilocarpine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—urinary bladder cancer	4.35e-05	0.000915	CbGpPWpGaD
Pilocarpine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—urinary bladder cancer	4.31e-05	0.000906	CbGpPWpGaD
Pilocarpine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—urinary bladder cancer	4.31e-05	0.000906	CbGpPWpGaD
Pilocarpine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—urinary bladder cancer	4.29e-05	0.000903	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—TYMP—urinary bladder cancer	4.14e-05	0.000872	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—GLI1—urinary bladder cancer	4.12e-05	0.000868	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—GLI1—urinary bladder cancer	4.11e-05	0.000865	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—RRM2—urinary bladder cancer	4.09e-05	0.000861	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—GLI1—urinary bladder cancer	4.07e-05	0.000856	CbGpPWpGaD
Pilocarpine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—urinary bladder cancer	4.07e-05	0.000856	CbGpPWpGaD
Pilocarpine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—urinary bladder cancer	4.06e-05	0.000853	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—RRM2—urinary bladder cancer	3.84e-05	0.000807	CbGpPWpGaD
Pilocarpine—CHRM1—Circadian rythm related genes—TP53—urinary bladder cancer	3.82e-05	0.000803	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—ENO2—urinary bladder cancer	3.79e-05	0.000797	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—HPGDS—urinary bladder cancer	3.79e-05	0.000797	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—NAT2—urinary bladder cancer	3.75e-05	0.000788	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—GSTT1—urinary bladder cancer	3.68e-05	0.000773	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—HPGDS—urinary bladder cancer	3.55e-05	0.000748	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—ENO2—urinary bladder cancer	3.55e-05	0.000748	CbGpPWpGaD
Pilocarpine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—urinary bladder cancer	3.46e-05	0.000727	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—GSTT1—urinary bladder cancer	3.45e-05	0.000725	CbGpPWpGaD
Pilocarpine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—urinary bladder cancer	3.45e-05	0.000725	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	3.35e-05	0.000704	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR ligand binding—CXCL8—urinary bladder cancer	3.32e-05	0.000699	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR ligand binding—CXCL8—urinary bladder cancer	3.31e-05	0.000697	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR ligand binding—CXCL8—urinary bladder cancer	3.28e-05	0.00069	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—RRM2—urinary bladder cancer	3.23e-05	0.00068	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	3.17e-05	0.000667	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—NAT1—urinary bladder cancer	3.17e-05	0.000667	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—NQO1—urinary bladder cancer	3.06e-05	0.000643	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—HPGDS—urinary bladder cancer	3e-05	0.00063	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—ENO2—urinary bladder cancer	3e-05	0.00063	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—GSTT1—urinary bladder cancer	2.91e-05	0.000611	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	2.9e-05	0.00061	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—NQO1—urinary bladder cancer	2.87e-05	0.000603	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—RBX1—urinary bladder cancer	2.83e-05	0.000595	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—RBX1—urinary bladder cancer	2.82e-05	0.000593	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—RBX1—urinary bladder cancer	2.79e-05	0.000587	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—TSC1—urinary bladder cancer	2.66e-05	0.000559	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—TSC1—urinary bladder cancer	2.65e-05	0.000557	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—TSC1—urinary bladder cancer	2.62e-05	0.000552	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	2.61e-05	0.00055	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—GSTP1—urinary bladder cancer	2.55e-05	0.000536	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—JAG1—urinary bladder cancer	2.53e-05	0.000532	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—JAG1—urinary bladder cancer	2.52e-05	0.000531	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—JAG1—urinary bladder cancer	2.5e-05	0.000525	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	2.47e-05	0.000519	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—NQO1—urinary bladder cancer	2.41e-05	0.000508	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	2.4e-05	0.000506	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—GSTP1—urinary bladder cancer	2.39e-05	0.000503	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—TYMS—urinary bladder cancer	2.37e-05	0.000498	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—NCOR1—urinary bladder cancer	2.34e-05	0.000493	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—GSTM1—urinary bladder cancer	2.34e-05	0.000493	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—GPX1—urinary bladder cancer	2.24e-05	0.000472	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—TYMS—urinary bladder cancer	2.22e-05	0.000467	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—ERCC2—urinary bladder cancer	2.2e-05	0.000463	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—GSTM1—urinary bladder cancer	2.2e-05	0.000462	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—NCOR1—urinary bladder cancer	2.2e-05	0.000462	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—RHOA—urinary bladder cancer	2.14e-05	0.00045	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—RHOA—urinary bladder cancer	2.13e-05	0.000448	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—RHOA—urinary bladder cancer	2.11e-05	0.000444	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—GPX1—urinary bladder cancer	2.1e-05	0.000442	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—MTHFR—urinary bladder cancer	2.07e-05	0.000435	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—ERCC2—urinary bladder cancer	2.06e-05	0.000434	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—S100B—urinary bladder cancer	2.05e-05	0.000431	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—S100B—urinary bladder cancer	2.04e-05	0.00043	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—S100B—urinary bladder cancer	2.02e-05	0.000425	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—GSTP1—urinary bladder cancer	2.01e-05	0.000424	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—RHOA—urinary bladder cancer	1.94e-05	0.000409	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—MTHFR—urinary bladder cancer	1.94e-05	0.000408	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—RHOA—urinary bladder cancer	1.94e-05	0.000407	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.92e-05	0.000404	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—RHOA—urinary bladder cancer	1.92e-05	0.000403	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—CXCL8—urinary bladder cancer	1.88e-05	0.000395	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—TYMS—urinary bladder cancer	1.87e-05	0.000394	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—CXCL8—urinary bladder cancer	1.87e-05	0.000394	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—CXCL8—urinary bladder cancer	1.85e-05	0.00039	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—NCOR1—urinary bladder cancer	1.85e-05	0.000389	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—GSTM1—urinary bladder cancer	1.85e-05	0.000389	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—NCOR1—urinary bladder cancer	1.84e-05	0.000388	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—NCOR1—urinary bladder cancer	1.84e-05	0.000386	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—NCOR1—urinary bladder cancer	1.82e-05	0.000383	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—IL2—urinary bladder cancer	1.79e-05	0.000377	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—IL2—urinary bladder cancer	1.79e-05	0.000376	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—GPX1—urinary bladder cancer	1.77e-05	0.000373	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—IL2—urinary bladder cancer	1.77e-05	0.000373	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—ERCC2—urinary bladder cancer	1.74e-05	0.000366	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.74e-05	0.000366	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—CXCL8—urinary bladder cancer	1.71e-05	0.000359	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—CXCL8—urinary bladder cancer	1.7e-05	0.000358	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—CXCL8—urinary bladder cancer	1.68e-05	0.000354	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—PPARG—urinary bladder cancer	1.68e-05	0.000353	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—MTHFR—urinary bladder cancer	1.64e-05	0.000344	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—IL2—urinary bladder cancer	1.63e-05	0.000343	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—IL2—urinary bladder cancer	1.62e-05	0.000342	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—TERT—urinary bladder cancer	1.62e-05	0.000342	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—TERT—urinary bladder cancer	1.62e-05	0.00034	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—CREBBP—urinary bladder cancer	1.61e-05	0.000339	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—IL2—urinary bladder cancer	1.61e-05	0.000338	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—TERT—urinary bladder cancer	1.6e-05	0.000337	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—PPARG—urinary bladder cancer	1.57e-05	0.000331	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—CREBBP—urinary bladder cancer	1.51e-05	0.000318	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.5e-05	0.000316	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—FGFR3—urinary bladder cancer	1.49e-05	0.000313	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—FGFR3—urinary bladder cancer	1.49e-05	0.000312	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—FGFR3—urinary bladder cancer	1.47e-05	0.000309	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—ESR1—urinary bladder cancer	1.45e-05	0.000304	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—ESR1—urinary bladder cancer	1.44e-05	0.000303	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—ESR1—urinary bladder cancer	1.43e-05	0.000301	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.39e-05	0.000292	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.39e-05	0.000292	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.35e-05	0.000284	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PPARG—urinary bladder cancer	1.33e-05	0.000279	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—PTGS2—urinary bladder cancer	1.32e-05	0.000278	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—CREBBP—urinary bladder cancer	1.27e-05	0.000268	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CREBBP—urinary bladder cancer	1.27e-05	0.000267	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CREBBP—urinary bladder cancer	1.26e-05	0.000266	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—IGF1—urinary bladder cancer	1.25e-05	0.000263	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CREBBP—urinary bladder cancer	1.25e-05	0.000263	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—IGF1—urinary bladder cancer	1.25e-05	0.000263	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—EGFR—urinary bladder cancer	1.25e-05	0.000262	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—EGFR—urinary bladder cancer	1.24e-05	0.000261	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—PTGS2—urinary bladder cancer	1.24e-05	0.00026	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—IGF1—urinary bladder cancer	1.24e-05	0.00026	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—EGFR—urinary bladder cancer	1.23e-05	0.000259	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—KRAS—urinary bladder cancer	1.18e-05	0.000248	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—KRAS—urinary bladder cancer	1.17e-05	0.000247	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—KRAS—urinary bladder cancer	1.16e-05	0.000244	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—PTEN—urinary bladder cancer	1.15e-05	0.000242	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—RHOA—urinary bladder cancer	1.15e-05	0.000241	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—RHOA—urinary bladder cancer	1.14e-05	0.000241	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—RHOA—urinary bladder cancer	1.13e-05	0.000238	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.12e-05	0.000236	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—EP300—urinary bladder cancer	1.1e-05	0.000231	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—PTEN—urinary bladder cancer	1.08e-05	0.000227	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—ERBB2—urinary bladder cancer	1.06e-05	0.000223	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—ERBB2—urinary bladder cancer	1.06e-05	0.000223	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—ERBB2—urinary bladder cancer	1.05e-05	0.000221	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PTGS2—urinary bladder cancer	1.04e-05	0.000219	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—EP300—urinary bladder cancer	1.03e-05	0.000217	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CXCL8—urinary bladder cancer	1.01e-05	0.000212	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CXCL8—urinary bladder cancer	1e-05	0.000211	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—HRAS—urinary bladder cancer	1e-05	0.000211	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—HRAS—urinary bladder cancer	9.98e-06	0.00021	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CXCL8—urinary bladder cancer	9.94e-06	0.000209	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—HRAS—urinary bladder cancer	9.88e-06	0.000208	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—IL2—urinary bladder cancer	9.63e-06	0.000202	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—IL2—urinary bladder cancer	9.6e-06	0.000202	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—IL2—urinary bladder cancer	9.5e-06	0.0002	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CCND1—urinary bladder cancer	9.38e-06	0.000197	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CCND1—urinary bladder cancer	9.35e-06	0.000197	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	9.34e-06	0.000197	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CCND1—urinary bladder cancer	9.26e-06	0.000195	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—MMP9—urinary bladder cancer	9.11e-06	0.000192	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PTEN—urinary bladder cancer	9.1e-06	0.000191	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—MMP9—urinary bladder cancer	9.08e-06	0.000191	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CDKN1A—urinary bladder cancer	9.08e-06	0.000191	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PTEN—urinary bladder cancer	9.06e-06	0.000191	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CDKN1A—urinary bladder cancer	9.05e-06	0.00019	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PTEN—urinary bladder cancer	9.03e-06	0.00019	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—MMP9—urinary bladder cancer	8.99e-06	0.000189	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CDKN1A—urinary bladder cancer	8.96e-06	0.000189	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PTEN—urinary bladder cancer	8.94e-06	0.000188	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	8.69e-06	0.000183	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—EP300—urinary bladder cancer	8.68e-06	0.000183	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—EP300—urinary bladder cancer	8.64e-06	0.000182	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—EP300—urinary bladder cancer	8.61e-06	0.000181	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	8.59e-06	0.000181	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	8.59e-06	0.000181	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—EP300—urinary bladder cancer	8.53e-06	0.000179	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—SRC—urinary bladder cancer	8.4e-06	0.000177	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—SRC—urinary bladder cancer	8.37e-06	0.000176	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—SRC—urinary bladder cancer	8.29e-06	0.000174	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	8.22e-06	0.000173	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	8.07e-06	0.00017	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	7.59e-06	0.00016	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—MYC—urinary bladder cancer	7.53e-06	0.000158	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—MYC—urinary bladder cancer	7.5e-06	0.000158	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—MYC—urinary bladder cancer	7.43e-06	0.000156	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—EGFR—urinary bladder cancer	7.36e-06	0.000155	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—EGFR—urinary bladder cancer	7.34e-06	0.000154	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—EGFR—urinary bladder cancer	7.27e-06	0.000153	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—KRAS—urinary bladder cancer	6.95e-06	0.000146	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—KRAS—urinary bladder cancer	6.93e-06	0.000146	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—KRAS—urinary bladder cancer	6.87e-06	0.000144	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—TP53—urinary bladder cancer	6.18e-06	0.00013	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—TP53—urinary bladder cancer	6.16e-06	0.00013	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	6.15e-06	0.000129	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—TP53—urinary bladder cancer	6.1e-06	0.000128	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—HRAS—urinary bladder cancer	5.91e-06	0.000124	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	5.91e-06	0.000124	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—HRAS—urinary bladder cancer	5.89e-06	0.000124	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—HRAS—urinary bladder cancer	5.84e-06	0.000123	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	4.84e-06	0.000102	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	4.22e-06	8.88e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—EP300—urinary bladder cancer	4.03e-06	8.47e-05	CbGpPWpGaD
